Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Ostergaard

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Plos One|July 7, 2011
Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individualsAnne Roslev Bukh, Jesper Melchjorsen, Rasmus Offersen, et al.
Transplantation|February 9, 2005
Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantationThomas C Kotsimbos, Gregory I Snell, Bronwyn Levvey, et al.
Virology Journal|August 3, 2011
Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particlesTea Kirkegaard, Adam Wheatley, Jesper Melchjorsen, et al.
Journal of Neuroimmunology|February 11, 2014
Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccinesHayk Davtyan, Anahit Ghochikyan, Armine Hovakimyan, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
BMJ Open|October 29, 2013
Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort studyBo Langhoff Hønge, Sanne Jespersen, Pernille Bejer Nordentoft, et al.
Vaccine|February 5, 2016
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adultsLars Ostergaard, Gregg H Lucksinger, Judith Absalon, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 29, 2015
Diabetes mellitus prevalence in tuberculosis patients and the background population in Guinea-Bissau: a disease burden study from the capital BissauThorny L Haraldsdottir, Frauke Rudolf, Morten Bjerregaard-Andersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2025
Immunogenicity and Safety of the COVID-19 mRNA Vaccine Coadministered with Influenza and 23-valent Pneumococcal Polysaccharide VaccinesOmid Rezahosseini, Jens Ulrik Stæhr Jensen, Hana Khajeh Rahimi, et al.
Plos One|January 12, 2012
Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNARandi K Berg, Jesper Melchjorsen, Johanna Rintahaka, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Plos One|July 7, 2011
Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individualsAnne Roslev Bukh, Jesper Melchjorsen, Rasmus Offersen, et al.
Transplantation|February 9, 2005
Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantationThomas C Kotsimbos, Gregory I Snell, Bronwyn Levvey, et al.
Virology Journal|August 3, 2011
Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particlesTea Kirkegaard, Adam Wheatley, Jesper Melchjorsen, et al.
Journal of Neuroimmunology|February 11, 2014
Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccinesHayk Davtyan, Anahit Ghochikyan, Armine Hovakimyan, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
BMJ Open|October 29, 2013
Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort studyBo Langhoff Hønge, Sanne Jespersen, Pernille Bejer Nordentoft, et al.
Vaccine|February 5, 2016
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adultsLars Ostergaard, Gregg H Lucksinger, Judith Absalon, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 29, 2015
Diabetes mellitus prevalence in tuberculosis patients and the background population in Guinea-Bissau: a disease burden study from the capital BissauThorny L Haraldsdottir, Frauke Rudolf, Morten Bjerregaard-Andersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2025
Immunogenicity and Safety of the COVID-19 mRNA Vaccine Coadministered with Influenza and 23-valent Pneumococcal Polysaccharide VaccinesOmid Rezahosseini, Jens Ulrik Stæhr Jensen, Hana Khajeh Rahimi, et al.
Plos One|January 12, 2012
Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNARandi K Berg, Jesper Melchjorsen, Johanna Rintahaka, et al.
Pageof 8